PYLOTUM > Projects


A major goal pursued by Pylotum is to study the origin of H. pylori related gastric cancer to develop novel means of prevention, risk stratification, diagnosis and therapeutic interventions for gastric cancer patients. Our ongoing trials will help to determine the impact of H. pylori eradication on gastric cancer development as well as to identify novel biomarkers and future therapeutic targets to treat gastric tumors. An experienced international interdisciplinary team and a state-of-the-art infrastructure ensure the success of our research projects.

Linqu Trial

Since 2011 we are conducting a large randomized controlled intervention trial at Linqu County in order to assess whether gastric cancer incidence, which is extremely high in this area.
Read More

Endoscopy Trial

This study is an important next step after the ongoing “Large-Linqu-Trial”, addressing histopathologic, serologic and molecular biomarkers for assessment of gastric cancer risk.
Read More

Biomarkers for Gastric Cancer

The main objective of this project is to identify novel biomarkers for gastric cancer associated with H. pylori infection, and to build a predictive model that allows patient stratification.
Read More

Funded by: Federal Ministry of Education and Research (BMBF)  |  Ministry of Science and Technology of the People’s Republic of China  |  Beijing Municipal Science and Technology Commission